Identification

Symbol
ALTKA
ISIN code
FR0010999425
Exchange / Market
Euronext
Trading location
Paris
Products family
Stocks
Market organization
EuronextParis
ICB
Medical Supplies
Activity description

Tekka was founded in the year 2000. The company’s principal activity is the development, production and marketing of cranio-maxillo-facial surgery products (launched in 2000), dental implants (launched in 2004), and orthodontic products (launched in 2005).
Dental Implants should account for c. 80% of turnover in fiscal year ending 2011. The company mainly operates in France, but is expanding geographically.

Tekka Group specializes in designing, producing, and selling medical implants and devices used in the fields of cranio-maxillo-facial surgery, orthodontia, and implantology. Sales break down by activity as follows:

  • sales of dental implants and prostheses (74.9%);
  • sales of maxillo-facial surgical devices (23.3%);
  • sales of orthodontic anchoring systems (1.3%);
  • supply of services (0.5%): primarily training services.

90.3% of sales are in France.

Website address
www.tekka.eu

Operation

IPO date
Tue 08/02/2011
IPO type

Public Offer on NYSE Alternext in Paris

IPO type
Initial Public offering
Catégorie
IPO
Operation calendar

The first trading of new and existing shares will take place as from 14/02/2011 on a single quotation line 'TEKKA GROUP' under the code 'TEKKA GROUP' ISINcode FR0010999425, trading symbol ALTKA.